Roivant Sciences Ltd
Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies. It was founded in 2014 by Vivek Ramaswamy and is currently headed by CEO Matt Gline. Roivant maintains its headquarters in New York City as well as major offices in the biotech hubs of Boston and Basel.
If you'd bought from year…
Same habit, different start year. Each row shows what a constant habit's worth of ROIV would be worth today, had you started buying at that point in the asset's history.
| Started | $6/day$6/day coffee | $42/wk$42/week coffee |
|---|---|---|
| Year 1 (2020) — listing | $27,865 3.4× | $40,748 3.4× |
| Year 6 (2025) | $4,231 2.0× | $6,189 2.0× |
Repeated investment, no fees, dividends reinvested. $6/day coffee = $180 / month equivalent.
Popular scenarios with ROIV
For illustration only — not investment advice. Past performance is not indicative of future results.